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Summary. Peyronie's disease (PD) is a localized
disorder of the connective tissue of the tunica albuginea
(TA) whose etiology has not been elucidated. Although
several studies have implicated genetic susceptibility
and/or mechanical trauma as triggering events for PD,
the underlying molecular mechanisms remain largely
unknown. Aquaporin 1 (AQP1) is a water channel
protein potentially implicated in connective tissue
resistance to mechanical stress, acting primarily by
increasing tension within the collagen network.
Although it represents a potentially attractive molecular
target in PD, to date no studies had ever addressed
whether AQP1 is detectable and/or differentially
expressed in the TA of these patients. 
Herein the present study, through immunohisto-
chemical and biochemical approaches, we were able to
detect AQP1 expression in the TA of control and PD
affected patients. 
We demonstrated that AQP1-like immunoreactivity
and expression are significantly increased in plaques of
PD patients Vs controls, implying that AQP1 over-
expression might be the consequence of a localized
maladaptive response of the connective tissue to
repeated mechanical trauma. 
In summary, these data support the idea that AQP1
might represent a potentially useful biomarker of
mechanical injury in the TA and a promising target for
the treatment of PD. 
Key words: Aquaporin 1, Tunica albuginea, Peyronie’s
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Introduction
Peyronie's disease (PD), also known as induratio
penis plastica, is a disorder of the connective tissue of
the penile tunica albuginea (TA) with a multifaceted
etiopathogenesis (Jordan et al., 1998; Noss et al., 2000;
Hellstrom and Bivalacqua, 2000; Gholami and Lue,
2001). It is characterized by the formation of one or
more subcutaneous fibrous plaques on the shaft of the
penis, an increase and disorganization of collagen fibers,
and elastic fiber fragmentation. Plaque formation may
cause the characteristic penile deformity and/or
curvature, which in turn may result in pain during sexual
activity, erectile dysfunction, and which seems to be
accompanied by biomolecular changes, including
apoptosis activation (Hellstrom and Vivalacqua, 2000;
Davila et al., 2003; Costa et al., 2008; Gholami and Lue,
2011; Kadioglu et al., 2011; Loreto et al., 2011, 2014;
Sansalone et al., 2012).
TA is the main tissue affected by PD. It is a thick
fibrous envelope that surrounds each cylinder of the
corpora cavernosa (CC); it mostly consists of collagen
fibers, but it also contains rich elastic and smooth muscle
fibers. Interestingly, previous evidence has shown TA
structural integrity is partly regulated by androgens,
targeting extracellular matrix (ECM) and affecting
smooth muscle to connective tissue ratio, in order to
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maintain both fibroelastic properties and penile tissue
compliance to mechanic stress (Traish et al., 1999;
Traish and Kim, 2005). Therefore, it is likely that other
molecules endowed with homeostatic effects on ECM
properties might be differentially regulated in the TA
between control and PD patients. Indeed, previous
studies from our research group and others have
identified aquaporin-1 (AQP1) as a potential candidate
involved in ECM regulation and maintenance in several
healthy (Richardson et al., 2008; Loreto et al., 2012a)
and diseased tissues (Loreto et al., 2012b; Musumeci et
al., 2013, 2015a). At present, however, whether or not
AQP1 is detectable in the TA has never been assessed.
Literature data on the pathophysiological underlying
mechanisms of PD plaques reported an increase in
microvascular permeability, persistent fibrin (deficient
fibrinolysis) and collagen buildup, perivascular
inflammation, disruption and loss of elastic fibers,
disorganized collagen bundles with a conversion of
collagen type I in to III with an overall imbalance
between profibrotic (tumor growth factor-β1, fibrin,
plasminogen activator inhibitor-1, tissue inhibitors of
metalloproteinases, etc) and antifibrotic (metallo-
proteases, etc.) processes (Somers and Dawson, 1997;
Hellstrom and Bivalacqua, 2000; Gelbard, 2008;
Gholami and Lue, 2011; Zorba et al., 2012; Gokce et al.,
2014; Loreto et al., 2014).
AQPs are integral membrane proteins involved in
the formation of pores in cellular membranes. These
proteins are broadly distributed in various tissues and
have been detected in fibrocartilage and similar tissues
such as the intervertebral disc (IVD) (Richardson et al.,
2008; Loreto et al., 2012a,b). AQPs are specific protein
channels for water transport that have been shown to
play an important role in tissue strength in relationship
to tension and shear forces (Borgnia et al., 1999;
Ishibashi et al., 2000; Verkman and Mitra, 2000;
Richardson et al., 2008). The family of AQPs may be
divided into two groups based on structural and
functional differences. Group 1 members (AQP1, 2, 4, 6,
and 8) are primarily water selective channels, whilst
group 2 members (AQP3, 7, 9, and 10), namely
aquaglyceroporins, transport glycerol and other small
molecules, including urea (Wang et al., 2007; Verkman,
2009). AQPs expression has been studied in various
tissues and organs such as kidney, respiratory tract,
brain, eye, gastrointestinal tract (Ma and Verkman, 1999;
van Os et al., 2000). They exert an important role in
water movement across the membrane, for active near-
isosmolar fluid absorption/secretion, neuronal signal
transduction, cell metabolism and proliferation
(Verkman, 2009). Specifically, AQP1 has been
investigated in articular chondrocytes (Mobasheri et al.,
2004), chondrocyte-like cells of human IVD
(Richardson et al., 2008), temporomandibular joint disc
(Loreto et al., 2012a,b), human synovial membrane
(Mobasheri et al., 2010) and in osteoarthritic knee
meniscus (Musumeci et al., 2013). 
To date, the underlying cause of PD has not been
characterized, but trauma or mechanical stress to the TA
during sexual intercourse are thought to be the major
causative factors (Gelbard et al., 1990). Unfortunately,
despite efforts to find an effective target for drug
treatment, the only currently available option for PD
management or cure remains surgery to repair or
reconstruct the damaged TA (Ralph et al., 2010; Levine,
2011; Sansalone et al., 2012). Nonetheless, an increasing
number of observations have suggested that AQP1,
through its ability to induce water entry inside the cell,
may increase tension within the collagen network (Meng
et al., 2007; Loreto et al., 2012a,b), thereby leading to an
overall increase in tissue resistance to mechanic stress.
This concept has raised the possibility that AQP1 might
indeed play a central adaptive function in response to
mechanical forces, like those affecting TA during sexual
intercourse. 
In the present study we explored this possibility by
assessing (i) whether AQP1 is detectable in the TA and
(ii) whether its expression levels are changed in the TA
of patients affected by PD.
The findings provided in this study indicate that
AQP1 expression, although at low levels, is normally
detectable in healthy TA tissue. Interestingly, a
remarkable increase of AQP1-like immunoreactivity and
expression can be observed in PD plaques from PD
patients. Based on these data, it is suggested that a
localized maladaptive induction of AQP1 in the TA of
PD patients, likely due to repeated mechanical trauma,
may contribute to trigger plaque formation and, as a
consequence, penile deformation. 
Materials and methods
Patients and tissue collection
Biopsy specimens (wedge shaped, approximately
5×3 mm) of PD plaques were collected from 15
Caucasian patients (mean age 53±10 years; range 31-67)
with stable PD for at least 6 months at the level of the
corporotomy during corrective surgery for PD. All
patients underwent albugineal grafting using the
geometrical principle, as originally described by Egydio
and Sansalone (2008). The TA was incised and grafted at
the level of the maximum curvature, where plaque was
most prominent.
The study was approved by the local ethics
committee. The informed consent of all participants was
obtained before tissue collection. The study protocol was
approved by the ethics committee of the Clinic of
Urology, Clinical Center Nis, Nis, Serbia. 
On preoperative examination, all patients reported
spontaneous erections, but being prevented from having
regular sexual intercourse by a penile curvature >45°.
Degree of curvature and rigidity were evaluated with
Doppler ultrasound after intracavernous injection of
alprostadil 10-20 µg. The curvature was ventral in 5
patients, lateral in 3, and dorsal in 7 patients, and was
consistently >70%.
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The control samples were from 4 Caucasian patients
(mean age 23±3.0 years; range 21-27) with congenital
penile curvature, who underwent Nesbit's corrective
procedure (Nesbit, 1965), a limitation since acquiring a
real healthy tissue biopsy may prove challenging and
ethically questionable. Their clinical histories were
negative for generalized penile diseases and none had
macroscopic signs of degenerative or inflammatory
disorders. 
Staining of these specimens with Mayer's
hematoxylin showed no detectable pathological
abnormalities on light microscopic examination.
Immunohistochemistry
For the immunohistochemical studies, the TA
samples were fixed overnight in 10% neutral buffered
formalin (Bio-Optica, Milan, Italy) and then
demineralized in ethylenediaminetetraacetic acid
(EDTA) decalcification fluid (41.3 g disodium EDTA,
4.4 g NaOH in 1,000 mL distilled water) for 6 weeks at
4°C. After fixation and overnight washing, they were
dehydrated in graded ethanol and embedded in paraffin.
Specimens were then sectioned at a thickness of 5 µm
and placed on silanized glass slides. 
Sections were incubated for 30 min in 0.3%
H2O2/methanol to quench endogenous peroxidaseactivity and then rinsed for 20 min with phosphate-
buffered saline (PBS; Bio-Optica, Milan, Italy). The
sections were heated (5 min×3) in capped polypropylene
slide-holders filled with citrate buffer (10 mM citric
acid, 0.05% Tween 20, pH 6.0; Bio-Optica, Milan,
Italy), using a microwave oven (750 W) to unmask
antigenic sites. The blocking step was performed before
application of the primary antibody using normal goat
serum (Vector laboratories, CA, USA), 1:20 work
dilution in PBS-T, 1 h in a moist chamber.
Following the blocking step, sections were incubated
with a mouse monoclonal AQP1 antibody (Santa Cruz
Biotechnology, Inc., USA) diluted 1:100 in PBS and
incubated overnight at 4°C. The secondary antibody,
biotinylated anti-mouse antibody, was applied for 30 min
at room temperature, followed by the avidin-biotin-
peroxidase complex (Vector Laboratories, Chicago, IL,
USA) for a further 30 min at room temperature. The
immunoreaction was visualized by incubating the
sections for 4 min in a 0.1% 3,3’-diaminobenzidine and
0.02% hydrogen peroxide solution (DAB substrate kit,
Vector Laboratories, CA, USA). The sections were
lightly counterstained with Mayer's Hematoxylin
(Histolab Products AB, Goteborg, Sweden) mounted in
GVA mount (Zymed Laboratories Inc., San Francisco,
CA, USA) and observed with an Axioplan Zeiss light
microscope (Germany).
Quantification of immunoreactivity
The intensity of AQP1 staining and the proportion of
immunopositive cells were examined in blind by light
microscopy and recorded by two anatomists and a
histologist. Intensity of staining (IS) was ranked in a
semiquantitative manner using a 5-point scale, as
follows: 0=no detectable staining, 1=weak staining,
2=moderate staining, 3=strong staining, 4=very strong
staining. The proportion of AQP1-immunopositive cells
(extent score=ES) was evaluated independently by two
anatomists and a histologist and scored as a proportion
of 100 cells into four categories: 0≤5%; 1=6-30%; 2=31-
50%; 3≥50%, and 4≥75%. Counting was performed at
200× magnification. The final staining score (FSS) was
the sum of IS + ES.
Software-aided quantif ication of AQP1-like
immunoreactivity
Five fields, randomly selected from each section,
were analyzed and the percentage of area stained with
the AQP1 antibody was calculated using image analysis
software (AxioVision Release 4.8.2 - SP2 Software, Carl
Zeiss Microscopy GmbH, Jena, Germany), which
quantifies the level of staining intensity of positive
immunolabelling in each field, as described previously
(Musumeci et al., 2013). Digital photomicrographs were
taken using the Zeiss Axioplan light microscope (Carl
Zeiss, Oberkochen, Germany, using objective lens with
magnification x20 i.e. final magnification 400x) fitted
with a digital camera (AxioCam MRc5, Carl Zeiss,
Oberkochen, Germany); evaluations were made by three
blinded investigators, whose evaluations were assumed
to be correct if values were not significantly different. In
case of dispute concerning interpretation, the samples
were re-evaluated in order to reach unanimous
agreement.
Protein extraction
Fresh TA tissue was extracted using a buffer
containing 20 mM Tris (pH 7.4), 2 mM EDTA, 0.5 mM
EGTA; 50 mM mercaptoethanol, 0.32 mM sucrose and a
protease inhibitor cocktail (Roche Diagnostics) using a
Teflon-glass homogenizer and then sonicated twice for
20 sec using an ultrasonic probe, followed by
centrifugation at 10.000 g for 10 min at 4°C. Protein
concentrations were determined by the Quant-iT Protein
Assay Kit (Invitrogen) (Castorina et al., 2012).
Western Blot Analysis
Western blot analysis was performed to determine
the relative expression levels of AQP1 protein in the TA
of control and PD patients. Analysis was performed
following procedures recently described with minor
modifications (Castorina et al., 2014). Sample proteins
(30-35 μg) were diluted in 2X Laemmli buffer
(Invitrogen, Carlsbad, CA, USA), boiled at 95°C for 5
min and then separated on a Biorad Criterion XT 4-15%
Bis-tris gel (Invitrogen) by electrophoresis and then
transferred to a nitrocellulose membrane (Invitrogen).
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Blots were blocked using the Odyssey Blocking Buffer
(Li-Cor Biosciences). The transfer was monitored using
a prestained protein molecular weight marker (BioRad
Laboratories). Immunoreaction was carried out using the
following primary antibodies: a mouse monoclonal
AQP1 (cat n. sc-25287, Santa Cruz Biotechnology;
1:200) and a rabbit anti-β-tubulin (cat n.sc-9104, Santa
Cruz Biotechnology; 1:500) which was used to assess
equal protein loading. The secondary antibodies were a
goat anti-mouse IRDye 680CW, (cat#926-68020D; Li-
Cor Biosciences) and a goat anti-rabbit IRDye 800CW,
(cat #926-32211; Li-Cor Biosciences), which were used
at a dilution of 1:30000 and 1:20000, respectively. Blots
were scanned with an Infrared Imaging System
(Odyssey). Densitometric analyses of Western blot
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Fig. 1. A. Negative control (primary antibody omitted) showing the
absence of immunoreactivity. B. Representative immunostaining for
AQP1 in control samples of tunica albuginea from a subject without
Peyronie’s disease. B’. Magnification of the inset in (B): AQP1-
immunopositiveness in fibroblasts and myofibroblasts. Scale bars: A, B,
50 μm; B’, 15 μm.
signals were performed at non-saturating exposures and
analyzed using the ImageJ software (NIH, Bethesda,
MD; available at http://rsb.info.nih.gov/ij/index.html).
Values were normalized to β-tubulin, which served as
loading control. No signal was detected when the
primary antibody was omitted (data not shown). 
Statistical analysis
Quantitative results are reported as mean ± standard
error of the mean (SEM). Data were analyzed with the
SPSS program (SPSS® release 16.0, Chicago, IL, USA)
and found to be normally distributed using Student's t-
test. Statistical comparisons between control and PD
subjects were evaluated using the unpaired two-tailed
Student t-test. Changes were accepted as significant only
when p values were ≤0.05.
Results
Prior to immunohistochemical evaluations to assess
AQP1 immunoreactivity we performed histopathological
assessments of the TA in all participants. Hematoxylin
staining carried out in sections from PD plaques
obtained from PD subjects evidenced typical histological
signatures indicating the presence of a pathological
fibrotic process (data not shown). More specifically, in
comparison to TAs from control patients the
arrangement of the collagen fiber network appeared
altered at various extents in all PD samples examined,
and clear signs of damage ranging from fiber
fragmentation to tears and splitting were visible
throughout the sections appraised. Further signs of
structural disassembly of the normal collagen fiber
network and arrangement were also noted. Indeed,
elastic fibers lost their classic homogenous distribution
and were partially fragmented, with spare presence of
collagen bundles that formed clumps with surrounding
elastic fibers throughout the plaques.
As opposite to PD patients, all control TA samples
had preserved collagen bundles and regular longitudinal
fiber orientation in the outer layer and circular bundles
in the inner layer.
Immunohistochemical analyses of biopsy specimens
showed that AQP1-like immunoreactivity was barely
detectable in control TAs (IS=1; ES: 0-1) (Fig. 1). When
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Fig. 2. A. Negative control (primary antibody omitted) showing the absence of
immunoreactivity. B. AQP1 immunostaining in the Peyronie’s disease plaque
from a patient with Peyronie’s disease. B’. Magnification of the inset in (B):
AQP1-like immunoreactivity in fibroblasts and myofibroblasts. Scale bars: A,
B, 50 μm; B’, 15μm.
present, immunostained cells consisted primarily of
fibroblasts and myofibroblasts, respectively. AQP1
subcellular localization was mainly at the cellular
membrane, but was also found in the cytoplasm and in
some cases in the perinuclear space (Figs. 1, 2).
Comparative estimation of AQP1-like reactivity score in
TA from control and PD patients revealed that the
proportion of immunopositive cells and the intensity of
the immunoreaction in PD patients were much higher
than in normal tissue (IS=4; ES: 4). The mean FSS of
PD plaques was 6.84 ± 0.82 (range 4.9-8.5). Results
from image analyses consistently showed that AQP1
immunosignal was significantly increased in TA tissues
from PD subjects (t=12.43, ***p<0.001 Vs Ctrl;
Unpaired two-tailed Student t-test) (Fig. 3), in agreement
with FSS data. Finally, Western blot analyses carried out
on tissue lysates from control and PD TAs and related
quantifications using the freely available ImageJ
software further confirmed that AQP1 protein expression
was increased at statistically significant levels in PD Vs
control samples (t16=12.8, p<0.0001 Vs Ctrl; Unpairedtwo-tailed Student t-test, Fig. 4).
Discussion
As far as we are concerned, the present study is the
first one demonstrating that AQP1 is expressed in the TA
surrounding the corpora cavernosa of the penis. In
addition, throughout these studies we were also able to
show that AQP1 relative protein expression and
immunoreactivity levels are significantly augmented in
the TA tissue from PD patients with respect to control
subjects, arguing for the possibility that this water
channel protein might indeed play a critical role in the
pathogenesis of the disease.
AQP1 is a 28-kDa integral membrane protein first
isolated in 1988 from the plasma membranes of red cells
and renal tubules (Denker et al., 1988) whose function,
based on its amino acid sequence and topographic
distribution, has been associated to water or perhaps
other fluids entry inside the cell. In fact, its
homotetrameric structure physically resembles that of a
typical water channel (Fushimi et al., 1993) and the
constitutively high expression levels detected in the
proximal tubules and the descending thin limbs of the
loops of Henle support a role for this protein in the
regulation of water homeostasis in the kidneys (King et
al., 2001). However, AQP1 is also expressed in many
other tissues/organs and its function is not limited to
renal water clearance. In fact, in recent years a growing
number of studies have begun to support a role for
AQP1 in tissue compliance to mechanical stress,
suggesting that it may indeed act as an adaptive
molecule whose induction is dependent on the
mechanical stimuli received by the tissue, i.e. tension,
shear forces and/or injury (Borgnia et al., 1999; Ishibashi
et al., 2000; Verkman and Mitra, 2000; Richardson et al.,
2008). While this could also be applicable to different
types of connective tissue, to date it has never been
assessed whether AQP1 is detectable in the TA, and its
specific contribution in relation to PD physiology has
not been investigated. Furthermore, it has never been
established whether AQP1 is involved in the
pathogenesis of PD. 
In an attempt to provide a preliminary comparative
assessment of AQP1 distribution in TAs from control
and PD patients to each of these issues, in the present
work we performed a series of pilot experiments using
biopsy specimens of TA from both control and PD
patients. Firstly, we performed a histopathological
evaluation on PD plaques. As opposed to control TAs,
diseased PD plaques from PD patients showed the
typical pathological hallmarks of a fibrotic tissue, with a
disorganized collagen meshwork and interrupted elastic
fibers. Immunohistological assessments revealed
low/absent AQP1-like immunoreactivity in controls
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Fig. 4. A representative Western blot (Upper panel) and related
densitometric analysis of AQP1 protein expression (Lower panel)
obtained using 30-35 μg of tissue lysates from the tunica albuginea of
control and Peyronie’s disease affected patients (n=3 per group) after
electrophoretic separation using a gradient (4-12%) SDS-PAGE. β-
tubulin was used as the loading control. Results are the mean
normalized optical density (OD) ± SEM obtained from at least three
independent determinations. For further details on the procedures
please refer to the appropriate section in Matrerial and methods.
p<0.0001 Vs control TA, as calculated using the unpaired two-tailed
Student t-test.
Fig. 3. Quantification of AQP1-like immunoreactivity in the tunica
albuginea of control Vs Peyronie’s disease patients (n=5 sections per
group). Results shown are the percentage of area stained with the
AQP1 antibody, which was calculated using image analysis software
(AxioVision Release 4.8.2 - SP2 Software, Carl Zeiss Microscopy
GmbH, Jena, Germany), which quantifies the level of staining intensity
of positive immunolabelling in each field, as described previously.
***p<0.001 Vs control TAs, as determined by unpaired two-tailed
Student t-test. (Musumeci et al., 2015b).
(Figs. 1, 3), whereas signal intensity ranged from strong
to very strong in all PD plaques resected from PD
patients (Figs. 2, 3). In agreement with these data,
immunoblot analyses confirmed the statistically
significant increase of AQP1 protein abundance in 
PD plaques when compared to control tissues (Fig. 
4). 
While PD is known to be characterized by localized
TA disruption, loss of elastic fibers, disorganized
collagen bundles, and a site-specific increase in
microvascular permeability (Somers and Dawson, 1997;
Shindel et al., 2010; Young et al., 2010), the molecular
switches underlying disease onset and progression have
not received much attention. The few available
mechanistic studies are those that have taken advantage
of rat models locally injected with transforming growth
factor-β1 (TGF-β1), a cytokine that seems to be able to
induce the formation of PD-like plaques similar to that
observed in human PD patients (Dahiya and Lue, 1997;
El-Sakka et al., 1998; Gonzalez-Cadavid and Rajfer,
2009). But if local injection of TGF-β1can effectively
induce plaque pathology, then it is possible that the
cytokine can also induce AQP1 expression since
elevated TGF-β1has consistently been found in all PD
patients examined in the study. Unfortunately, in
relationship to the potential transcriptional regulation of
the different AQP subtypes by TGF-β1, data in the
literature is divergent. Indeed, an independent research
group has documented that TGF-β1 acts as a potent
inducer of AQP5 in peritoneal mesothelial cells (Ryu et
al., 2012), where it promotes regenerative processes,
whereas others have shown that AQP1 expression is
inversely correlated with TGF-β1 in kidneys (Li et al.,
2012), suggesting that TGF-β1 regulatory actions on the
several AQP subtypes might be different and/or cell-type
specific. Based on these findings and on the AQP1
increase observed in the TA from PD plaques in the
course of our investigations, we believe that mechanical
stimulation, likely occurring during sexual intercourse,
might trigger an initial inflammatory response in a
restricted area of the penile shaft with pre-existing
structural weaknesses, to then cause the local release of
TGF-β1. Under physiological conditions, such an
increase in cytokine levels is transient, and not sufficient
to trigger structural changes at the site of action and/or
induction of AQP1 in the stimulated TA. Conversely,
repeated and localized trauma may cause sustained local
inflammation of the TA in weaker zones and this, in turn,
might lead to the upregulation of AQP1 in the attempt to
increase tissue compliance to mechanic stress as a
“forced” compensative mechanism, but that ultimately
results in local tissue fibrosis. 
Alternatively, it is also possible that TGF-β1 may
directly induce fibrosis by promoting fibroblast-to-
myofibroblast transition and collagen synthesis and that
induction of AQP1 occurs to re-establish normal
physiology of the connective tissue by counteracting
these cellular processes through mechanisms that are
still unknown. However, this theory still remains to be
ascertained. With this in mind, further studies addressing
how the different AQPs regulated in the TA as well as
the intracellular signaling pathways activated are
warranted in order to gain further insights on the
involvement of these molecules in the pathogenesis of
the disease, but also to set the stage to finding targeted
non-surgical therapies to cure or prevent PD. 
In conclusion AQP1 is detectable, although at low
levels, in the TA surrounding the corpora cavernosa of
the penis. Its expression is significantly upregulated in
PD plaques from patients affected by Peyronie’s disease,
suggesting a role of AQP1 in the remodeling process of
TA and supporting a potential pathophysiological role of
this water channel protein in the onset or progression of
the disease. It is also possible to speculate that patients
in whom AQP1 expression cannot increase are more
prone to developing PD due to mechanical stress. 
Additional in vitro studies are clearly required to
gain further insights into the pathophysiological
mechanism of this molecule and identify drugs that can
influence this process.
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